カテゴリー： IMARC, 世界, 医療/バイオ

乳房病変局在化法の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23FB0182）◆商品コード：IMARC23FB0182
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年2月1日
◆ページ数：143
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥449,850見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥599,850見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥749,850見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社の市場調査資料によると、2022年に1,102.8百万ドルであった世界の乳房病変局在化法市場規模は2028年に2,018.5百万ドルまで拡大し、2023年から2028年の間にCAGR 10.1％増加すると見込まれています。当調査資料では、乳房病変局在化法の世界市場について調査し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（ワイヤー式局在化法、放射性同位体式局在化法、磁気トレーサー式局在化法、その他）分析、用途別（腫瘍同定、センチネルリンパ節同定）分析、エンドユーザー別（病院、診断センター、腫瘍クリニック、外来手術センター）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下の構成でまとめています。なお、当調査資料には、Argon Medical Devices Inc.、Becton Dickinson and Company、Cook Group Incorporated、CP Medical Inc. (Theragenics Corporation)、Endomagnetics Ltd.、Hologic Inc.、IsoAid LLC、IZI Medical Products (Landauer Inc)、Laurane Medical LLC、Leica Biosystems Nussloch GmbH (Danaher Corporation)、Merit Medical Systems Inc. and Sterylab S.r.l.などの企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の乳房病変局在化法市場規模：種類別
- ワイヤー式局在化法の市場規模
- 放射性同位体式局在化法の市場規模
- 磁気トレーサー式局在化法の市場規模
- その他乳房病変局在化法の市場規模
・世界の乳房病変局在化法市場規模：用途別
- 腫瘍同定における市場規模
- センチネルリンパ節同定における市場規模
・世界の乳房病変局在化法市場規模：エンドユーザー別
- 病院における市場規模
- 診断センターにおける市場規模
- 腫瘍クリニックにおける市場規模
- 外来手術センターにおける市場規模
・世界の乳房病変局在化法市場規模：地域別
- 北米の乳房病変局在化法市場規模
- アジア太平洋の乳房病変局在化法市場規模
- ヨーロッパの乳房病変局在化法市場規模
- 中南米の乳房病変局在化法市場規模
- 中東・アフリカの乳房病変局在化法市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競合状況

The global breast lesion localization methods market size reached US$ 1,102.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 2,018.5 Million by 2028, exhibiting a growth rate (CAGR) of 10.1% during 2023-2028.

Breast lesion localization methods refer to various procedures employed to detect abnormal changes in the breast tissue, also called a breast lesion, caused due to a disease or injury. Some commonly used methods include wire localization, carbon marking, radio-guided occult lesion localization (ROLL), radioactive seed localization (RSL), magnetic seed localization (Magseed), and intraoperative ultrasound (IOUS). These techniques assist doctors and healthcare professionals in making informed decisions and determining the ideal treatment or surgery for the patient. With advancements in surgical, imaging and biomedical technology, breast lesion localization methods have significantly evolved, which is presently driving their demand in the healthcare sector.

Breast Lesion Localization Methods Market Trends:
A significant increase in breast cancer cases due to changing lifestyles, and unhealthy diets represents the primary factor driving the market growth. Besides this, the growing number of patients requiring lumpectomy and surgical biopsy procedures is augmenting the demand for breast lesion localization methods to ensure accurate removal of the target lesion. Additionally, the governing agencies of various countries are taking favorable initiatives to spread awareness regarding the benefits of early detection of breast cancer. For instance, the Government of Australia launched BreastScreen Australia, a national breast cancer screening program that provides a free mammogram to women aged 50-74 every two years. This, in confluence with the increasing number of government and private reimbursement policies for breast cancer diagnosis, biopsy and other related medical procedures and the launch of innovative breast lesion localization devices by leading players, is catalyzing the market growth. Furthermore, heavy investments in research and development (R&D) activities are offering lucrative opportunities to the market players. Other factors, including the rising number of individuals undergoing cosmetic surgeries like breast enhancement, improving healthcare infrastructure, technological advancements, and increasing consumer healthcare spending, are also creating a positive market outlook.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global breast lesion localization methods market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, usage and end user.

Breakup by Type:

Wire Localization
Radioisotope Localization
Magnetic Tracers Localization
Others

Breakup by Usage:

Tumor Identification
Sentinel Lymph Node Identification
Lumpectomy
Mastectomy

Breakup by End User:

Hospitals
Diagnostic Centres
Oncology Clinics
Ambulatory Surgical Centers

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Argon Medical Devices Inc., Becton Dickinson and Company, Cook Group Incorporated, CP Medical Inc. (Theragenics Corporation), Endomagnetics Ltd., Hologic Inc., IsoAid LLC, IZI Medical Products (Landauer Inc), Laurane Medical LLC, Leica Biosystems Nussloch GmbH (Danaher Corporation), Merit Medical Systems Inc. and Sterylab S.r.l.

Key Questions Answered in This Report
1. What was the size of the global breast lesion localization methods market in 2022?
2. What is the expected growth rate of the global breast lesion localization methods market during 2023-2028?
3. What are the key factors driving the global breast lesion localization methods market?
4. What has been the impact of COVID-19 on the global breast lesion localization methods market?
5. What is the breakup of the global breast lesion localization methods market based on type?
6. What is the breakup of the global breast lesion localization methods market based on the usage?
7. What is the breakup of the global breast lesion localization methods market based on the end user?
8. What are the key regions in the global breast lesion localization methods market?
9. Who are the key players/companies in the global breast lesion localization methods market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Breast Lesion Localization Methods Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Wire Localization
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Radioisotope Localization
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Magnetic Tracers Localization
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Usage
7.1 Tumor Identification
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Sentinel Lymph Node Identification
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Lumpectomy
7.2.2.2 Mastectomy
7.2.3 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Diagnostic Centres
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Oncology Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Ambulatory Surgical Centers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Argon Medical Devices Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Becton Dickinson and Company
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Cook Group Incorporated
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 CP Medical Inc. (Theragenics Corporation)
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Endomagnetics Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Hologic Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 IsoAid LLC
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 IZI Medical Products (Landauer Inc)
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Laurane Medical LLC
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.10 Leica Biosystems Nussloch GmbH (Danaher Corporation)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Merit Medical Systems Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sterylab S.r.l
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 乳房病変局在化法の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Breast Lesion Localization Methods Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 血液浄化装置の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • カプノグラフィ装置の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 血管内温度管理の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 医療用フォームの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 心電計（ECG）の世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆